Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 10, 2001, Pages 1555-1561

  Corleto, V D ^a   Annibale, B ^a   Gibril, F ^b   Angeletti, S ^a   Serrano, J ^b   Venzon, D J ^c   Delle Fave, G ^a   Jensen, R T ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; CANCER DIAGNOSIS; DRUG USE; ENDOCRINE TUMOR; GASTRINOMA; GASTROINTESTINAL TUMOR; HUMAN; ITALY; MAJOR CLINICAL STUDY; MASKING; PATIENT REFERRAL; PRIORITY JOURNAL; UNITED STATES; ZOLLINGER ELLISON SYNDROME;

ANTI-ULCER AGENTS; COSTS AND COST ANALYSIS; HISTAMINE H2 ANTAGONISTS; HUMANS; ITALY; OMEPRAZOLE; PROTON PUMPS; REFERRAL AND CONSULTATION; UNITED STATES; ZOLLINGER-ELLISON SYNDROME;

EID: 0034799474     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01085.x     Document Type: Article

References (34)

1. Gastrinoma
2. The Zollinger-Ellison syndrome: Re-appraisal and evaluation of 260 registered cases
3. Thirty years' experience with gastrinoma
4. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas
5. Zollinger-Ellison syndrome: Current concepts in diagnosis and management
6. Use of omeprazole and other proton pump inhibitors in the Zollinger-Ellison syndrome
7. Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome
8. Zollinger- Ellison syndrome: Current concepts and management
9. Use of omeprazole in Zollinger-Ellison: A prospective nine-year study of efficacy and safety
10. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis
11. Long term omeprazole treatment in man: Effects on gastric endocrine cell populations
12. Consequences of gastric acid inhibition in man
13. Gastrinoma as a model for prolonged hypergastrinemia in man
14. Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients
15. Clinical features and advances in biological diagnostic criteria for Zollinger-Eiiison syndrome
16. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study
17. Imaging for pancreatic endocrine tumor localization: Recent advances
18. Surgery to cure the Zollinger-Ellison syndrome
19. Somatostatin receptor localization of pancreatic endocrine tumors
20. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: A prospective study
21. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1
22. Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification
23. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome; the best approach
24. Diagnosis and management of Zollinger-Ellison syndrome
25. Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high
26. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome
27. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h
28. Zollinger-Ellison syndrome: Clinical presentation, pathology, diagnosis and treatment
29. Zollinger-Ellison syndrome: Clinical presentation in 261 patients
30. Surgical treatment of localized gastrinoma within the liver: A prospective study
31. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma
32. Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome
33. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study
34. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma